Found: 6
Select item for more details and to access through your institution.
Antiglaucoma drug GLC756 and its effect on cellular cAMP and tumor necrosis factor α release in vitro of activated human monocytic leukemia cells.
- Published in:
- Japanese Journal of Ophthalmology, 2009, v. 53, n. 2, p. 159
- By:
- Publication type:
- Article
Imaging dopamine D<sub>4</sub> receptors in the living primate brain: A positron emission tomography study using the novel D<sub>1</sub>/ D<sub>4</sub> antagonist [<sup>11</sup>C]SDZ GLC 756.
- Published in:
- Synapse, 1998, v. 30, n. 4, p. 341, doi. 10.1002/(SICI)1098-2396(199812)30:4<341::AID-SYN1>3.0.CO;2-6
- By:
- Publication type:
- Article
Identification of Dopamine 'D3′' and 'D4′' Binding Sites, Labelled with [<sup>3</sup>H]2-Amino-6,7-Dihydroxy- 1,2,3,4- Tetrahydronaphthalene, as High Agonist Affinity States of the D1 and D2 Dopamine Receptors, Respectively.
- Published in:
- Journal of Neurochemistry, 1986, v. 46, n. 4, p. 1058, doi. 10.1111/j.1471-4159.1986.tb00618.x
- By:
- Publication type:
- Article
Untersuchungen über Enzymaktivitäten der Leberzelle bei Vitamin-E-Mangel.
- Published in:
- Helvetica Chimica Acta, 1972, v. 55, n. 2, p. 519, doi. 10.1002/hlca.19720550223
- By:
- Publication type:
- Article
Effects of latanoprost, timolol and GLC756, a novel dopamine D<sub>2</sub> agonist and D<sub>1</sub> antagonist on LTC<sub>4</sub> release after rat mast cell activation.
- Published in:
- Clinical & Experimental Ophthalmology, 2007, v. 35, n. 7, p. 645, doi. 10.1111/j.1442-9071.2007.01560.x
- By:
- Publication type:
- Article
Effect of adding the D1 agonist CY 208-243 to chronic bromocriptine treatment. I: Evaluation of motor parameters in relation to striatal catecholamine content and dopamine receptors.
- Published in:
- Movement Disorders, 1993, v. 8, n. 2, p. 144, doi. 10.1002/mds.870080205
- By:
- Publication type:
- Article